The ‘Cancer translated’ blog top ten posts of 2016

The OHSU Knight Cancer Institute’s "Cancer translated" blog explores new findings, ideas and debates in cancer medicine, from basic biology, to clinical trials, to prevention, survivorship and...

Predicting colon polyp risk from microRNA

Differences in microRNA in colon polyps may help identify high risk cases that require more frequent follow-up screening, according to a study with four OHSU co-authors that is featured on the cover...

Blood test for cancer early detection? A giant study is underway

Grail Inc., a startup with investors including Microsoft's Bill Gates and Amazon's Jeff Bezos, made a splash earlier this year when it unveiled plans to develop a blood-based screening test for...

Making better decisions to prevent colon cancer

Colorectal cancer mortality rates (per 100,000) are as much as six times higher in red counties than in those colored dark blue. (Source: NCI SEER data 2007-2011) To prevent deaths from colon...

The promise of early detection

Nearly a century ago, a Greek immigrant physician in New York City began refining microscopy techniques for examining cells gently scraped from the female reproductive tract. The results were...

Advancing a potential blood test for pancreatic cancer

Immunovia’s "IMMray" technology uses an antibody microarray to detect the protein signature of pancreatic cancer in blood samples. The Swedish biotech firm Immunovia reached another milestone...

Ambiguous breast biopsies often “overinterpreted”

Pathologists’ tendency to overinterpret breast biopsies may be contributing to the problem of breast cancer overdiagnosis. That’s according to a report this week in Annals of Internal Medicine...